Online citations, reference lists, and bibliographies.
← Back to Search

Biodegradable, Polymeric Nanoparticle Delivery Systems For Cancer Therapy.

Eric M. Pridgen, R. Langer, O. Farokhzad
Published 2007 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology has the potential to impact the treatment of cancer significantly. This review will explore how this potential is beginning to be realized through the design of polymeric nanoparticle delivery systems. Current research is focused on developing biocompatible nanoparticles capable of targeting specific cancer markers and delivering imaging and therapeutic agents for the detection and treatment of cancer, resulting in a number of preclinical and clinical applications. More sophisticated nanoparticle designs are now in development, including particles able to release multiple drugs for enhanced treatment efficacy and targeted, multifunctional particles capable of combining imaging and drug release.
This paper references
10.1021/BC030028A
Polyacetal-doxorubicin conjugates designed for pH-dependent degradation.
R. Tomlinson (2003)
10.1016/S0959-8049(03)00273-9
Exploiting the hallmarks of cancer: the future conquest of breast cancer.
G. Sledge (2003)
10.1021/JA057712F
Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging.
K. Kim (2006)
10.1021/BC060035+
Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas.
X. Montet (2006)
10.1038/35078107
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Sayda M. Elbashir (2001)
10.1021/JM060515M
Multivalent effects of RGD peptides obtained by nanoparticle display.
X. Montet (2006)
10.1021/LA061834J
Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles.
J-J Yuan (2006)
10.1016/J.BIOMATERIALS.2006.09.047
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
J. Cheng (2007)
10.1038/NBT0697-542
αv Integrins as receptors for tumor targeting by circulating ligands
R. Pasqualini (1997)
10.1021/MP060107E
Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells.
C. Solbrig (2007)
10.1021/NL0519229
Polymeric nanoparticle preparation that eradicates tumors.
J. Mccarthy (2005)
10.1038/nbt1171
Designing dendrimers for biological applications
C. C. Lee (2005)
10.1021/BM060815L
Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells.
A. Myc (2007)
10.1016/J.ADDR.2005.09.019
Dendrimer biocompatibility and toxicity.
R. Duncan (2005)
10.1016/J.BIOMATERIALS.2006.05.016
Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells.
I. Steinhauser (2006)
10.1021/MP0500014
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
10.1016/S0163-7827(03)00033-X
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
S. Moghimi (2003)
10.1158/0008-5472.CAN-06-1648
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
Lilian E van Vlerken (2007)
10.1016/J.BIOMATERIALS.2006.11.039
Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.
Wei Yang Seow (2007)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1016/S1389-0352(99)00004-5
Aptamers as therapeutic and diagnostic agents.
E. Brody (2000)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/S0168-3659(02)00088-3
Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages.
H. Yoo (2002)
10.1016/S0142-9612(00)00115-0
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
R. Jain (2000)
10.1016/J.JCONREL.2003.09.013
An overview of current delivery systems in cancer gene therapy.
Anas El-Aneed (2004)
10.1038/83324
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
M. Kay (2001)
10.1158/0008-5472.CAN-04-2550
Nanoparticle-Aptamer Bioconjugates
O. Farokhzad (2004)
10.1021/BM060182A
Temperature-sensitive pluronic/poly(ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment.
S. Choi (2006)
10.1021/MA0106346
Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery
D. Luo (2002)
10.1016/S0378-5173(03)00128-5
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
10.1021/MA0108867
Pendent Chain Functionalized Polyacetals That Display pH-Dependent Degradation: A Platform for the Development of Novel Polymer Therapeutics
R. Tomlinson (2002)
10.1073/PNAS.0407218101
A polymer library approach to suicide gene therapy for cancer.
D. Anderson (2004)
10.1023/A:1011054123304
Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups
S. Moghimi (2004)
10.1016/j.ymthe.2004.11.015
Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters).
D. Anderson (2005)
10.1038/nm1101-1241
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
M. Zhao (2001)
10.1016/S0169-409X(02)00046-7
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.
T. Merdan (2002)
10.1021/BM0506142
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
I. Majoros (2006)
10.1021/LA052710U
Fluorescence-modified superparamagnetic nanoparticles: intracellular uptake and use in cellular imaging.
F. Bertorelle (2006)
10.1002/JBM.A.30781
Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI.
C. Sun (2006)
10.1073/pnas.0607705103
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
C. Lee (2006)
10.1073/pnas.0610298104
Biomimetic amplification of nanoparticle homing to tumors
D. Simberg (2007)
10.1016/J.ADDR.2012.09.011
Delivery of molecular and cellular medicine to solid tumors.
R. Jain (2012)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1158/0008-5472.CAN-03-2798
Novel Nanosensors for Rapid Analysis of Telomerase Activity
J. Grimm (2004)
10.1016/J.JCONREL.2004.02.003
Folate receptor targeted biodegradable polymeric doxorubicin micelles.
H. Yoo (2004)
10.1021/BC0600968
Biodegradable polymeric vectors for gene delivery to human endothelial cells.
J. Green (2006)
10.1016/J.CHEMBIOL.2006.11.015
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
Seungpyo Hong (2007)
Drug delivery and targeting.
R. Langer (1998)
10.1021/BC00023A007
Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging.
L. Tiefenauer (1993)
10.1073/PNAS.0601755103
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
10.1166/JNN.2006.429
Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness.
C. Prego (2006)
10.3892/OR.13.6.1003
Nanotechnology blooms, at last (Review).
E. Gordon (2005)
10.1021/BC050176W
Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle.
Michael J. Heffernan (2005)
10.1016/S0065-2571(00)00013-3
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
H. Maeda (2001)
10.1038/nbt876
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
10.1038/sj.gt.3302425
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
B. Urban-Klein (2005)
10.1038/346818A0
In vitro selection of RNA molecules that bind specific ligands
A. Ellington (1990)
10.1080/02656730110108785
Magnetically mediated hyperthermia: current status and future directions
P. Moroz (2002)
10.1080/02652040110055261
Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.
R. Raghuvanshi (2001)
10.1021/NL061412U
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.
N. Nasongkla (2006)
10.1002/mrm.10406
MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
D. Artemov (2003)
10.1016/S0169-409X(00)00131-9
Delivery of molecular and cellular medicine to solid tumors.
R. Jain (2001)
10.1016/S0168-3659(01)00319-4
Drug targeting using thermally responsive polymers and local hyperthermia.
D. E. Meyer (2001)
10.1158/0008-5472.CAN-05-0565
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
S. Hu-Lieskovan (2005)
10.1016/j.addr.2012.09.004
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Shive (1997)
10.1038/NMAT1737
Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer
Y. Wang (2006)
10.1002/ANIE.200502152
A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery.
K. Wood (2005)
10.1016/S0169-409X(01)00116-8
Mathematical modeling of bioerodible, polymeric drug delivery systems.
J. Siepmann (2001)
10.1023/A:1016085108889
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
M. P. Desai (2004)
10.1126/SCIENCE.1063273
Drugs on Target
R. Langer (2001)
10.1016/J.JCONREL.2006.05.028
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers.
Justin M Saul (2006)
10.1021/MP050023Q
Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.
T. D. Mccarthy (2005)
10.1038/nature03794
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Shiladitya Sengupta (2005)
10.1038/380364A0
Organ targeting In vivo using phage display peptide libraries
R. Pasqualini (1996)
10.1021/NL0617179
Nanoparticles for two-photon photodynamic therapy in living cells.
D. Gao (2006)
10.1002/ANIE.200602251
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.
Vaishali Bagalkot (2006)
10.1038/nm1486
In vivo imaging of siRNA delivery and silencing in tumors
Z. Medarova (2007)
10.1016/S1367-5931(02)00347-2
Dendritic polymer macromolecular carriers for drug delivery.
A. Patri (2002)
10.1016/S1535-6108(03)00271-X
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.
J. Joyce (2003)
10.1080/02656730601175479
Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial
M. Johannsen (2007)
10.1023/A:1018908421434
Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release
H. Yoo (2004)
10.1023/A:1012126301290
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
M. P. Desai (2004)
10.3109/02656730903287790
Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia
A. Jordan (2009)
10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers.
J. Roberts (1996)
10.3109/10611869808997890
Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.
B. Bonnemain (1998)
Toward third-generation aptamers: Spiegelmers and their therapeutic prospects.
A. Vater (2003)
10.1200/JCO.2005.08.002
Nanoparticle albumin-bound paclitaxel for metastatic breast cancer.
M. Harries (2005)
10.1021/MP0500420
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
D. Shenoy (2005)
10.1093/NAR/GNH140
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
R. Schiffelers (2004)
10.1126/SCIENCE.1070200
Tumor Regression by Targeted Gene Delivery to the Neovasculature
J. Hood (2002)
10.3892/IJO.29.5.1053
Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience.
E. Gordon (2006)
10.1002/JPS.20646
Hyperthermia-induced antitumor activity of thermosensitive polymer modified temperature-sensitive liposomes.
H. Han (2006)



This paper is referenced by
10.2217/17435889.4.1.105
Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
M. Muthu (2009)
10.31489/2019ch3/68-75
Modification of carbon containing electrodes by aryldiazonium iodate salts for electroanalysis
A. O. Gusar (2019)
10.1002/PAT.1304
Polymers for targeted and/or sustained drug delivery
Joseph Jagur-Grodzinski (2009)
10.22028/D291-22721
Multilayer coating of gold nanoparticles (AuNP) with drug-polymer complex: Development and characterization
Nico Reum (2011)
Parallel algorithm of navier-stokes model for magnetic nanoparticles drug delivery system on distributed parallel computing system
Sakinah Abdul Hanan (2017)
10.1021/acs.chemrev.5b00321
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.
Alyssa B. Chinen (2015)
10.2217/nnm.09.44
Stimulus-responsive targeted nanomicelles for effective cancer therapy.
M. Muthu (2009)
10.3390/cancers11040515
Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
Amber Kerstetter-Fogle (2019)
10.2147/IJN.S227894
Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models
Sa-Hoe Lim (2019)
10.1016/B978-0-08-055294-1.00253-1
1.123 – Degradable Polymers
K.K.L. Phua (2011)
10.1016/j.ijpharm.2013.08.079
Nanocarriers for intravenous injection--the long hard road to the market.
M. Wacker (2013)
10.1177/1533033819853241
Inorganic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myelogenous Leukaemia
Youssef Ghosn (2019)
10.1016/j.ctrv.2012.02.003
Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
F. Yang (2012)
10.1002/adma.201306070
Development of intrinsically photoluminescent and photostable polylactones.
Zhiwei Xie (2014)
10.1002/PC.23861
Slow‐release nanopolymeric biodegradable composites holding doxorubicin and evaluation its antiproliferative potency on cancer
F. M. Helaly (2017)
10.1039/C4RA15727C
Cellular binding of nanoparticles disrupts the membrane potential.
Emilie A. K. Warren (2015)
10.1039/C1JM10712G
Polyamine–salt aggregate assembly of capsules as responsive drug delivery vehicles
H. Bagaria (2011)
10.1016/j.jconrel.2008.09.073
A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Einat Cohen-Sela (2009)
10.1016/j.ijpharm.2019.118729
Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
S. Vandghanooni (2019)
10.1021/mp900090z
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
Emily Gullotti (2009)
10.1016/j.colsurfb.2019.04.050
Hydrophobic drug self-delivery systems as a versatile nanoplatform for cancer therapy: A review.
P. Xue (2019)
10.1021/ar500190q
Nanoparticle–Cell Interactions: Molecular Structure of the Protein Corona and Cellular Outcomes
C. Fleischer (2014)
10.1063/1.4978642
Physics considerations in targeted anticancer drug delivery by magnetoelectric nanoparticles
Emmanuel Stimphil (2017)
10.1021/acsami.6b02828
Magnetic Cellulose Nanocrystal Based Anisotropic Polylactic Acid Nanocomposite Films: Influence on Electrical, Magnetic, Thermal, and Mechanical Properties.
P. Dhar (2016)
10.1002/marc.200900596
Multifunctional nanoscale platforms for targeting of the cancer cell immortality spectrum.
Venkataramanan Soundararajan (2010)
10.3390/nano8070486
Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
Yao Chen (2018)
10.1016/J.MOLSTRUC.2017.11.029
A nanocomplex of Cu(II) with theophylline drug; synthesis, characterization, and anticancer activity against K562 cell line
Maryam Sahlabadi (2018)
10.1002/adhm.201800711
Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation‐Caused Quenching Probes: Size‐Dependent Translocation via Oral Delivery
Haisheng He (2018)
10.1002/ADMA.201101646
Clicking well-defined biodegradable nanoparticles and nanocapsules by UV-induced thiol-ene cross-linking in transparent miniemulsions.
Jiong Zou (2011)
10.1007/978-3-642-14802-6_9
Uptake, Intracellular Localization and Biodistribution of Carbon Nanotubes
Vera Neves (2011)
10.1002/cmdc.200800091
Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
A. Wang (2008)
10.1007/978-3-319-22942-3_3
Polymeric Nanoparticles for Cancer Photodynamic Therapy.
C. Conte (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar